Stryker Corporation

Stryker Corporation

Company type	Public
Industry	Medical technology
Predecessor	The Orthopedic Frame Company
Founded	1941 (1941) in Kalamazoo, Michigan, United States
Founder	Homer Stryker
Headquarters	Kalamazoo , United States
Area served	Worldwide (over 100 countries)
Key people	Kevin A. Lobo (Chairman and CEO)
Products	Implants for joint replacement and trauma, surgical instruments and navigation technologies, endoscopic and communication tools, patient handling and emergency medical equipment, neurosurgical, neurovascular, and spinal devices
Number of employees	22000 (2012)
Website	stryker.com

Stryker Corporation is a U.S.-based multinational enterprise specializing in medical technology, with its headquarters located in Kalamazoo, Michigan. The company’s extensive range of products encompasses implants used in joint replacement and trauma procedures; surgical instruments and navigation technologies; endoscopic and communication tools; equipment for patient handling and emergency medical services; along with neurosurgical, neurovascular, and spinal devices applied across multiple medical disciplines.

Within the United States, Stryker sells its offerings directly to healthcare professionals, hospitals, and medical institutions. Internationally, the company maintains a presence in more than 100 countries through wholly owned subsidiaries, branches, and authorized third-party distributors.

Business segments

Stryker organizes its financial reporting into three primary divisions: Orthopedics, Medical and Surgical (MedSurg), and Neurotechnology and Spine.

• The Orthopedics segment specializes in implants designed for hip and knee replacements, trauma care, and surgeries involving extremities.
• MedSurg comprises surgical instruments and navigation systems (Instruments); endoscopic devices and communication systems (Endoscopy); patient handling apparatus and emergency medical products (Medical); along with reprocessed medical devices and other specialized items.
• Neurotechnology and Spine delivers neurosurgical and neurovascular solutions for minimally invasive endovascular interventions, brain and skull base operations, orthobiologics such as synthetic bone graft materials, vertebral augmentation technologies, as well as spinal implants targeting cervical, thoracolumbar, and interbody treatments for conditions related to injury, deformity, or degeneration.

History

The company originated in 1941 as The Orthopedic Frame Company, founded by Homer Stryker, an orthopedist from Kalamazoo, Michigan who graduated from the University of Michigan Medical School in 1925. Among his innovations were the Turning Frame—a mobile hospital bed—the cast cutter, and the walking heel. In 1964, the firm adopted the name Stryker Corporation.

After going public in 1979, Stryker expanded by acquiring companies such as Osteonics Corporation to enter the orthopedic implant sector. By 1999, annual revenues had reached $2.1 billion. The company was included in the S&P 500 and Forbes Platinum 400 lists by 2000 and became part of the Fortune 500 in 2002 with sales totaling $3 billion.

Stephen P. MacMillan assumed the roles of president and CEO in 2003. Sales increased to $4.9 billion by 2005. John W. Brown retired from his chairman position in 2010 while MacMillan remained CEO. In 2007, Stryker divested its Physiotherapy Associates unit for $150 million. Following MacMillan’s departure in 2012, Curt R. Hartman served as interim CEO until Kevin A. Lobo was named president and CEO later that year.

By the close of 2012, Stryker employed approximately 22,000 individuals worldwide with annual sales of $8.7 billion; roughly 35% of revenue was generated outside the U.S. In a global market analysis conducted that year, Stryker ranked tenth among medical technology companies with portfolio sales exceeding $8.6 billion. The company commanded about 35% of the global reconstructive market share, half of MedSurg’s market segment, and held a 15% share within Neurotechnology and Spine sectors.

Highlighted by Hermann Simon as an exemplar for small to medium-sized enterprises in his book Hidden Champions, Stryker continues to enhance its executive leadership team with recent appointments such as Rob Fletcher—formerly with Johnson & Johnson—as chief legal officer.

John Brown

Throughout a distinguished 32-year tenure at Stryker, Brown held the roles of president, CEO, and chairman. One account attributes to him the pivotal evolution of Stryker from a manufacturer of hospital beds into a premier global medical technology enterprise. , Brown's financial stake in Stryker positioned him on the Forbes 400 list, reflecting a net worth of .

Corporate governance

As of 2018, the composition of Stryker's board of directors was as follows:

• Kevin A. Lobo, chairman and CEO
• Allan C. Golston, lead independent director
• Mary K. Brainerd
• Srikant M. Datar, Ph.D.
• Dr. Roch Doliveux, DVM
• Louise L. Francesconi
• Sherilyn S. McCoy
• Andrew K. Silvernail
• Ronda E. Stryker
• Rajeev Suri
• John W. Brown, chairman emeritus
• Howard E. Cox, Jr, director emeritus

1998–2010

In 1998, Stryker purchased Howmedica, Pfizer’s orthopaedics division, for $1.65 billion, establishing Stryker Orthopaedics. Two years later, it acquired Guided Technologies, a firm specializing in optical localization systems for healthcare and industrial applications. Between 2002 and 2004, the company expanded its spinal device portfolio by acquiring Surgical Dynamics’ Spinal Implant Business for $135 million and SpineCore for $120 million. Entering the flexible endoscopy sector in 2006, Stryker obtained Israel-based Sightline Technologies and also acquired eTrauma.com to integrate PACS software solutions. Additionally, late in 2005, it secured PlasmaSol Corp., known for sterilization technologies used in MedSurg equipment.

In 2009, Stryker broadened its scope into medical device reprocessing through the acquisition of Ascent Healthcare Solutions.

2011–today

The year 2011 marked several strategic acquisitions: Boston Scientific’s Neurovascular Division was integrated to bolster stroke treatment offerings, alongside Orthovita for bone augmentation biomaterials. That same year included purchases of Memometal Technologies—specializing in shape memory metal products—and Concentric Medical for $135 million to enhance stroke intervention technologies.

In 2012, Stryker acquired Israeli company Surpass Medical Ltd., which develops flow diversion stents targeting brain aneurysms, for $135 million. The following year saw expansion into China with the acquisition of trauma device manufacturer Trauson Holdings and advancement in robotic-assisted surgery via MAKO Surgical Corporation.

Subsequent acquisitions encompassed Patient Safety Technologies (surgical sponge tracking systems), Pivot Medical (hip arthroscopy devices), Berchtold Holding AG (surgical tables and lighting), Small Bone Innovations Inc. for $358 million, and Turkish hospital bed producer Muka Metal A.S.

In 2016, Stryker made significant investments by acquiring Sage Products for $2.8 billion to address hospital-acquired infection prevention and Physio-Control from Bain Capital for $1.28 billion to enhance emergency medical solutions.

Between 2017 and 2018, the company continued its growth by acquiring Arthrogenx (arthroscopic repair devices), Novadaq for $700 million (imaging technologies), Vexim (€183 million spinal implants), Entellus Medical ($662 million ENT devices), K2M Group Holdings (complex spine solutions), Hygia Health Services, SafeAir AG, HyperBranch Medical Technology, and Invuity.

In 2019, acquisitions included Arrinex (cryoablation technology), Israeli firm OrthoSpace with a deal valued up to $220 million, Mobius Imaging, Cardan Robotics, and Wright Medical Group N.V., whose purchase cost approximately $4 billion including debt—significantly expanding Stryker’s upper-limb implant offerings.

During 2021-2022, key additions were OrthoSensor (joint replacement technology), TMJ Concepts, and digital health provider Vocera Communications in a transaction near $3 billion.

In 2023, the company introduced Prostep MIS Lapidus—a minimally invasive bunion correction system from its Wright Medical collection—aimed at lowering recurrence rates and reducing opioid dependency.

Among recent expansions are France-based joint replacement manufacturer SERF SAS acquired in March 2024 and AI-driven healthcare firm Care.ai obtained in September 2024.

Acquisition history

• Stryker Corporation (Founded in 1941 as The Orthopedic Frame Company)
  • Osteonics Corporation
  • Howmedica (Acquired 1998)
  • Leibinger GmbH (Acquired 1996)
  • Guided Technologies, Inc. (Divested 2007, SpineCore Inc.)
  • Water Street Healthcare Partners (Divested 2007)
  • Surgical Dynamics Inc. (Acquired 2002)
  • SpineCore Inc. (Acquired 2004)
  • PlasmaSol Corporation (Acquired 2005)
  • Sightline Technologies Ltd (Acquired 2006)
  • eTrauma.com Corporation (Acquired 2006)
  • Ascent Healthcare Solutions, Inc. (Acquired 2009)
  • Boston Scientific (Neurovascular division) (Acquired 2011)
  • Orthovita (Acquired 2011)
  • Memometal Technologies S.A. (Acquired 2011)
  • Concentric Medical, Inc. (Acquired 2011)
  • Trauson Holdings Company Limited (Acquired 2012)
  • MAKO Surgical Corporation (Acquired 2012)
  • Patient Safety Technologies (Acquired 2012)
  • Surpass Medical Ltd (Acquired 2012)
  • Pivot Medical, Inc. (Acquired 2014)
  • Berchtold Holding AG (Acquired 2014)
  • Small Bone Innovations Inc. (Acquired 2014)
  • Sage Products (Acquired 2016)
  • Physio-Control (Acquired 2016)
  • Stanmore Implants Worldwide Ltd (Acquired 2016)
  • Entellus Medical Inc (Acquired 2017)
  • Arthrogenx, LLC (Acquired 2017)
  • Novadaq (Acquired 2017)
  • Vexim (Acquired 2017)
  • Scopis GmbH (Acquired 2017)
  • K2M Group Holdings, Inc. (Acquired 2018)
  • Hygia Health Services (Acquired 2018)
  • SafeAir AG (Acquired 2018)
  • HyperBranch Medical Technology, Inc. (Acquired 2018)
  • Invuity, Inc (Acquired 2018)
  • Arrinex, Inc. (Acquired 2019)
  • OrthoSpace, Ltd (Acquired 2019)
  • GYS Tech, LLC (Acquired 2019)
  • Mobius Imaging, LLC (Acquired 2019)
  • Stryker B.V.
    • Stryker Unite, (Bermuda) Ltd
      • Wright Medical Group N.V. (Acquired 2019)
        • Wright Luxembourg S.A.
        • Wright Medical (Bermuda) Ltd
        • IMASCAP SAS (Acquired 2017)
        • Cartiva, Inc. (Acquired 2018)
  • OrthoSensor, Inc. (Acquired 2020)
  • TMJ Concepts (Acquired 2020)
  • Vocera Communications (Acquired 2021)
  • SERF SAS (Acquired 2024)
  • Care.ai (Acquired 2024)

Controversies and lawsuits

In January of the year 2000, Stryker revised its financial results for the fiscal year ending December 31, 1998, lowering acquisition-related expenses by $30.9 million.

Beginning in early 2007, the company was issued three FDA warning letters concerning regulatory compliance deficiencies at its manufacturing sites located in Ireland, New Jersey, and Massachusetts. These violations included procedural lapses, quality control shortcomings in hip implant components that led to revision surgeries, contamination by microbes in sterile packaging of implants, and falsified documentation associated with limited-use products. In response, Stryker dismissed the employees involved.

During the autumn of 2007, Stryker along with other orthopedic firms faced civil litigation initiated by the U.S. Department of Health and Human Services over alleged illicit kickbacks to physicians intended to influence hospital procurement decisions; the total settlement sought was $311 million. Nevertheless, Stryker avoided fines due to its prompt cooperation.

As of February 2008, there remained an unresolved dispute with the U.S. Department of Justice regarding the production of documents connected to allegations of misconduct in product sales.

In June and again in September of 2012, Stryker issued recalls for multiple versions of its Neptune Waste Management System medical vacuum devices following incidents including a fatality related to improper use; some units had been marketed without prior FDA clearance.

Litigation

In 2012, the FDA issued a cautionary notice regarding Stryker's Rejuvenate hip replacement system, identifying it as faulty and associated with adverse effects comparable to those found in DePuy hip devices. As a result, Stryker incurred penalties amounting to $3.5 billion in 2014 related to its Rejuvenate and ABG II hip implants, which were reported to cause intense pain.

In 2016, Stryker's subsidiary, Stryker EMEA Supply Chain Services BV, challenged the classification by Dutch regulators that categorized certain implant screws under procurement legislation. This dispute was escalated to the European Court of Justice for a preliminary ruling concerning the interpretation and applicability of pertinent EU laws.

Reaction to 2022 Russian Invasion of Ukraine

Amid the 2022 Russian military incursion into Ukraine, Stryker continued its operations within Russia, contrasting with over a thousand multinational corporations that either scaled back or halted their activities. The Yale School of Management assigned Stryker a "Grade F" under the "Digging In" category, signifying resistance to calls for withdrawal or operational reduction.

See also

• Invacare
• Össur